Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows a new revision tag (v3.5.4) indicating a newer build. This is a metadata update and does not change visible content or how the page functions.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s interface/version indicator was incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site update rather than a change to the study record.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This update does not change the study details or site content.SummaryDifference0.0%

- Check111 days agoChange DetectedGastric cancer was added to the list of studied conditions and a Genetics/Rare Diseases Information Center resource was included. The page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.